Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HeartBeam Inc. (BEAT:NASDAQ), powered by AI.
HeartBeam Inc. is currently trading at $0.72. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for HeartBeam Inc. on Alpha Lenz.
View HeartBeam Inc.'s valuation metrics on Alpha Lenz.
“HeartBeam Inc.'s ROE is -987.3%. Explore profitability and growth together.”
Ask for details →HeartBeam Inc. is a healthcare technology company focused on developing groundbreaking cardiac diagnostics solutions. Its primary function is to deliver innovative heart monitoring and diagnostic tools aimed at improving the accuracy and accessibility of cardiac care. The company's notable product offerings include wearable devices and software solutions designed to gather and analyze heart data in real-time, enabling faster and more precise detection of cardiac events. HeartBeam Inc. plays a crucial role in the healthcare technology sector by addressing urgent needs for timely diagnosis and management of heart conditions, potentially reducing the need for emergency interventions and hospitalizations. Through its advancements, HeartBeam influences both patient outcomes and the efficiency of healthcare providers, making it a significant player in the realm of digital health and telecardiology. Founded with a mission to harness technology for better cardiac health, HeartBeam continues to innovate within the niche of cardiovascular diagnostics, reflecting broader trends towards remote monitoring and personalized medicine.
“HeartBeam Inc.'s ROE is -987.3%. Explore profitability and growth together.”
Ask for details →HeartBeam Inc. (ticker: BEAT) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 19 employees.
The current price is $0.724 with a P/E ratio of -x and P/B of -x.
ROE is -987.32%.